These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 10553164

  • 1. Impact of immunophenotyping on management of acute leukemias.
    Béné MC, Bernier M, Castoldi G, Faure GC, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer M.
    Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
    [Abstract] [Full Text] [Related]

  • 2. New methodologic approaches for immunophenotyping acute leukemias.
    Basso G, Buldini B, De Zen L, Orfao A.
    Haematologica; 2001 Jul; 86(7):675-92. PubMed ID: 11454522
    [Abstract] [Full Text] [Related]

  • 3. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP.
    Medicina (B Aires); 2000 Jul; 60 Suppl 2():83-6. PubMed ID: 11188938
    [Abstract] [Full Text] [Related]

  • 4. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA, Sawadogo D, Mizero L, Salou M, Karim N, Sangaré A.
    Bull Soc Pathol Exot; 2004 Jul; 97(5):319-22. PubMed ID: 15787262
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and classification of the acute leukemias: recent advances and controversial issues.
    Taylor CG, Stasi R, Bastianelli C, Venditti A, Del Poeta G, Amadori S, Sargent J.
    Hematopathol Mol Hematol; 1996 Jul; 10(1-2):1-38. PubMed ID: 8792146
    [Abstract] [Full Text] [Related]

  • 6. Leukemias of indeterminant lineage.
    Lee EJ, Schiffer CA.
    Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibody panels for acute leukemia and myelodysplastic syndrome diagnosis. Results of a co-operative quality control group.
    Basso G, Bernasconi P, Chianese R, Crovetti G, Garbaccio G, Iavarone A, Pautasso M, Santagostino A, Stacchini A, Gruppo di Studio Policentrico sui Marcatori Immunologici.
    J Biol Regul Homeost Agents; 2001 Dec; 15(2):145-55. PubMed ID: 11501972
    [Abstract] [Full Text] [Related]

  • 8. Immunophenotyping of acute leukaemias.
    Béné MC.
    Immunol Lett; 2005 Apr 15; 98(1):9-21. PubMed ID: 15790504
    [Abstract] [Full Text] [Related]

  • 9. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J.
    Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681
    [Abstract] [Full Text] [Related]

  • 10. [Monoclonal antibodies in diagnosis of acute leukemias].
    Krawczyńska A, Robak T.
    Przegl Lek; 1996 Nov 12; 53(1):20-5. PubMed ID: 8711170
    [Abstract] [Full Text] [Related]

  • 11. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
    Ratei R, Sperling C, Ludwig WD.
    Ther Umsch; 1996 Feb 12; 53(2):88-96. PubMed ID: 8629269
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X.
    Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638
    [Abstract] [Full Text] [Related]

  • 13. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI.
    Cancer Res; 2001 Jun 01; 61(11):4483-9. PubMed ID: 11389079
    [Abstract] [Full Text] [Related]

  • 14. [Cytomorphology of acute mixed leukemia].
    Sucić M, Batinić D, Zadro R, Mrsić S, Labar B.
    Acta Med Croatica; 2008 Oct 01; 62(4):379-85. PubMed ID: 19205415
    [Abstract] [Full Text] [Related]

  • 15. [Multi-parametric analysis for leukemic immunophenotyping].
    Ujiie M, Sonoda A, Todoroki T, Amano H, Uchida T, Kawai Y, Watanabe K.
    Rinsho Byori; 1998 Nov 01; 46(11):1163-7. PubMed ID: 9868303
    [Abstract] [Full Text] [Related]

  • 16. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, Fonatsch C, Schwarzinger I.
    Am J Clin Pathol; 2002 Mar 01; 117(3):380-9. PubMed ID: 11888077
    [Abstract] [Full Text] [Related]

  • 17. Immunophenotypic diagnosis of acute leukemia by using decision tree induction.
    Cualing H, Kothari R, Balachander T.
    Lab Invest; 1999 Feb 01; 79(2):205-12. PubMed ID: 10068208
    [Abstract] [Full Text] [Related]

  • 18. Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).
    San-Miguel JF, Vidriales MB, Orfão A.
    Best Pract Res Clin Haematol; 2002 Mar 01; 15(1):105-18. PubMed ID: 11987919
    [Abstract] [Full Text] [Related]

  • 19. [Contribution of immunotyping in the diagnosis and in the prognosis of acute leukemia].
    Merle-Béral H, Boucheix C.
    Rev Prat; 1996 Jan 01; 46(1):30-6. PubMed ID: 8596888
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA, Fuller SG, Borowitz MJ.
    Cytometry B Clin Cytom; 2009 Mar 01; 76(2):150-5. PubMed ID: 18831072
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.